COMT Antibodies

Santa Cruz Biotechnology features a diverse variety of COMT monoclonal antibodies for investigating catechol-O-methyltransferase (COMT) function and regulation. COMT Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). COMT plays a central role in the metabolism of catecholamines, such as dopamine, epinephrine, and norepinephrine, by catalyzing their methylation. The enzymatic activity of catechol-O-methyltransferase maintains neurotransmitter balance in the body. Research has shown COMT involvement in various neurological and psychiatric disorders, including schizophrenia and mood disorders. Understanding catechol-O-methyltransferase function continues to be an important focus in developing therapeutic strategies for treating neurological conditions. Investigating COMT expression patterns helps reveal its role in different tissues and cellular compartments. Exploring COMT regulation provides insights into how cells control neurotransmitter levels. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of catechol-O-methyltransferase in health and disease, supporting progress in neuroscience and therapeutic development.